Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: A comparative study with p53 and Ki67 expression

British Journal of Cancer

Volumn 74, Issue 7, 1996, Pages 1056-1062

  Sanchez Beato M ^a   Martinez Montero J C ^a   Doussis Anagnostopoulou, T A ^b   Gatter, K C ^c   Garcia J ^a   Garcia J F ^a   Lloret, E ^a   Piris, M A ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Hodgkin's disease; Ki67; p53; Retinoblastoma; Tumour suppressor gene

Indexed keywords

CELL ANTIGEN; CELL PROTEIN; PHYTOHEMAGGLUTININ; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REED STERNBERG CELL; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 0029743494     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.489     Document Type: Article

References (38)

1. BUCHKOVICH K, DUFFY LA AND HARLOW E. (1989). The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58, 1097-1105.
2. CANCE WG, BRENNAN MF, DUDAS ME, HUANG C-M AND CORDON-CARDO C. (1990). Altered expression of the retinoblastoma gene product in human sarcomas. N. Engl. J. Med., 323, 1457-1462.
3. CATTORETTI G, BECKER MHG, KEY G, DUCHROW M, SCHLÜTER, GALLE J AND GERDES J. (1992). Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168, 357-363.
4. CORDN-CARDO C AND RICHON VM. (1994). Expression of the retinoblastoma protein is regulated in normal human tissues. Am. J. Pathol., 144, 500-510.
5. CORDON-CARDO C, WARTINGER D, PETRYLAK D, DALBAGNI G, FAIR WR, FUKS Z AND REUTER VE. (1992). Altered expression of the retinoblastoma gene product:prognostic indicator in bladder cancer. J. Natl Cancer Inst., 84, 1251-1256.
6. CHALLEPPAN SP, HIEBERT S, MUDRYJ M, HOROWITZ JM AND NEVINS JR. (1991). The E2F transcription factor is a cellular target for the Rb protein. Cell, 65, 1053-1061.
7. CHEN PL, SCULLY P, SHEW JY, WANG JY AND LEE WH. (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell, 58, 1193-1198.
8. DE CAPRIO JA, LUDLOW JW, FIGGE J, SHEW J-Y, HUANG C-M, LEE W-H, MARSILIO E, PAUCHA E AND LIVINGSTON DM. (1988). SV40 large tumour antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell, 54, 275-283.
9. DYSON N, HOWLEY PM, MÜNGER K AND HARLOW E. (1989). The human papilloma virus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science, 243, 934-937.
10. EGAN D, BAYLEY ST AND BRANTON PE. (1989). Binding of the Rb1 protein to E1A products is required for adenovirus transformation. Oncogene, 4, 383-388.
11. FIGGE J, BAKST G, WEISHEIT D, SOLIS O & ROSS JS. (1991). Image analysis quantification of immunoreactive retinoblastoma protein in human tyroid neoplasms with a streptavidin-biotin-peroxidase staining technique. Am. J. Pathol., 139, 1213-1219.
12. GINSGERG AM, RAFFELD M AND COSSMAN J. (1991). Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood, 77, 833-840.
13. HOROWITZ JM, PARK S-H, BOGENMANN E, GHENG J-C, YANDELL DW, KAYE FJ, MINNA JD, DRYJA TP AND WEINBERG RA. (1990). Frequent inactivation of the retinoblastoma antioncogene is restricted to a subset of human tumour cells. Proc. Natl Acad. Sci. USA, 87, 2775-2779.
14. HOROWITZ JM, YANDELL DW, PARK SH, CANNING S, WHYTE P, BUCHKOVIC K, HARLOW E, WEINBERG RA AND DRYJE TP. (1989). Point mutational inactivation of the retinoblastoma antioncogene. Science, 243, 937-940.
15. ISHIKAWA J, XU H-J, HU S-X, YANDELL DW, MAEDA S, KAMIDONO S, BENEDICT WF AND TAKAHASHI R. (1991). Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res., 51, 5736-5743.
16. KORNBLAU SM, CHEN N, DEL GIGLIO A, O'BRIEN S, & DEISSEROTH B. (1994). Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res., 54, 242-246.
17. LEE WH, BOOKSTEIN RE AND LEE EYHP. (1990). Molecular biology of the human retinoblastoma gene. In Tumour Suppressor Genes, Klein G. (ed.). pp. 169-199. Marcel Dekker: New York
18. LEES JA, BUCHKOVICH KJ, MARSHAK DR, ANDERSON CW AND HARLOW E. (1991). The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J., 10, 4279-4290.
19. LIN BT-Y, GRUENWALD S, MORLA AO, LEE W-H AND WANG JYJ. (1991). Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J., 10, 857-864.
20. MARTINEZ JC, PIRIS MA, SANCHEZ-BEATO M, VILLUENDAS R, ORRADRE JL, ALGARA P, SANCHEZ-VERDE L AND MARTINEZ P. (1993) Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction. J. Pathol., 169, 405-412.
21. MARTINEZ JC, MATEO M, SANCHEZ-BEATO M, VILLUENDAS R, ORRADRE JL, ALGARA P, SANCHEZ-VERDE L, GARCIA P, LOPEZ C, MARTINEZ P AND PIRIS MA. (1995). MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression. J. Pathol., 177, 27-34.
22. MATEO MS, SANCHEZ-BEATO M, MARTINEZ JC, ORFAO A, ORRADRE JL AND PIRIS MA. (1995). P53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections. J. Clin. Pathol., 48, 151-159.
23. MIHARA K, CAO XR, YEN A, CHANDLER S, DRISCOLL B, MURPHREE AL, T'ANG A AND FUNG Y-KT. (1989). Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science, 246, 1300-1303.
24. SCHOUTEN HC, SANGER WG, DUGGAN M, WEISENBURGER DD, MACLENNAN KA AND ARMITAGE JO. (1989). Chromosomal abnormalities in Hodgkin's disease. Blood, 73, 2149-2154.
25. SHIMIZU E, COXON A, OTTERSON GA, STEINBERG SM, KRATZKE RA, KIM YW, FEDORKO J, OIE H, JOHNSON BE, MULSHINE JL, MINNA JD, GAZDAR AF AND KAYE FJ. (1994). Rb protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene, 9, 2441-2448.
26. SLEBOS RJC, LEE MH, PLUNKETT BS, KESSIS TD, WILLIAMS BO, JACKS T, KASTAN MB AND CHO KR (1994). p53-dependent G1 arrest involves pRb related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl Acad. Sci. USA, 91, 5320-5324.
27. STILGENBAUER S, DÖNERH, BULGAY-MÖRSCHEL M, WEITZ S, BENTZ M AND LICHTER P. (1993). High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood, 8, 2118-2124.
28. SZEKELY L, SELIVANOVA G, MAGNUSSON KP, KLEIN G AND WIMAN KG. (1993). EBNA-5, an Epstein Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl Acad. Sci. USA, 90, 5455-5459.
29. TERADA N, LUCAS JJ AND GELAND EW. (1991). Differential regulation of the tumour suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. J. Immunol., 147, 698-704.
30. TILLY H, BASTARD C, DELASTRE T, DUVAL C, BIZET M, LENOMARD B, DAUCE J-P, MONCONDUIT M AND PIGUET H. (1991). Cytogenetic studies in untreated Hodgkin's disease. Blood, 77, 1298-1304.
31. VENTER DJ, BEVAN KL, LUDWIG RL, RILEY TEW, JAT PS, TOMAS DGT AND NOBLE MD. (1991). Retinoblastoma gene deletions in human glioblastomas. Oncogene, 6, 445-448.
32. VINDELOV LL, CHRISTENSEN IJ AND NISSEN NI. (1983). A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 3, 323-327.
33. WHITE E. (1994). P53, guardian of Rb. Nature, 371, 21-22.
34. WHYTE P, BUCHKOVICH JJ, HOROWITZ JM, FRIEND SH, RAYBUCK M, WEINBERG RA AND HARLOW E. (1988). Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature, 334, 124-129.
35. WILLIAMS BR, REMINGTON L, ALBERT DM, MUKAI S, BRONSON RT AND JACKS T. (1994). Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet., 7, 480-484.
36. XIAO Z-X, CHEN J, LEVINE AJ, MODJTAHEDI N, XING J, SELLERS WR AND LIVINGSTON DM. (1995). Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature, 375, 694-697.
37. XU H-J, HU S-X, CAGLE PT, MOORE GE AND BENEDICT WF. (1991a). Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res., 51, 2735-2739.
38. XU H-J, XU S-X AND BENEDICT WF. (1991b). Lack of nuclear Rb protein staining in G0/middle G1 cells: correlation to changes in total Rb protein level. Oncogene, 6, 1139-1146.